Ketamine for depression

Ketamine is an anesthetic that acts as a rapid antidepressant, with effects within about 24 hours.  Since 2021, we have been studying subcutaneous esketamine for depression. Our data showed a 52% response rate and 30% remission rate. The ongoing second phase includes ketamine-assisted psychotherapy, aiming to improve outcomes. Our research also explores changes in molecular biomarkers.